LifeScan Diabetes Deal Brings $2.1 Billion

LifeScan Diabetes Deal Brings $2.1 Billion

by | Jun 14, 2018 9:57 am | Medical Devices, Private Equity | 0 comments

Johnson & Johnson’s (NYSE: JNJ) selling spree continued with the divestiture of LifeScan, Inc. for $2.1 billion. LifeScan is a leader in blood glucose monitoring products, serving approximately 20 million patients globally in more than 90 countries. LifeScan markets blood glucose monitoring systems for home and hospital use under the global brand, One Touch. The OneTouch portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. The buyer, Platinum Equity, made its offer in March 2018 after working with J&J to craft a deal to allow LifeScan to beome a standalone business that would continue to... Read More »
Ethicon Sells Its Advanced Sterilization Products for $2.7 Billion

Ethicon Sells Its Advanced Sterilization Products for $2.7 Billion

by | Jun 11, 2018 9:19 am | Medical Devices | 0 comments

Johnson & Johnson (NYSE: JNJ) subsidiary Ethicon last week sold its advanced sterilization products (ASP) business to Fortive Corporation (NYSE: FTV) for $2.7 billion. The ASP business is a global provider of innovative sterilization and disinfection solutions. It generated adjusted EBITDA margin of approximately 25% (unaudited) in 2017. Fortive is a diversified industrial growth company comprised of professional instrumentation and industrial technologies businesses. Fortive’s brands generated revenue of $6.7 billion in 2017. ASP’s products include the STERRAD system for sterilizing instruments and the EVOTECH and ENDOCLENS system for endoscope reprocessing and cleaning.... Read More »

Danaher Doubles Down on Blood Diagnostics

by | Sep 9, 2016 3:08 pm | Biotechnology | 0 comments

Danaher Corporation (NASDAQ: DHR) has set a new direction for itself, after spinning off its Test & Measurement segment, Industrial Technologies segment and its Retail/Commercial Petroleum platform into Fortive Corporation (NYSE: FTV) on July 2. Post-separation, the company is positioned as a global science and technology  innovator with more than 20 operating companies in the health care, environmental and industrial industries. In September, Danaher announced its acquisition of Cepheid (NASDAQ: CPHD ) for $3.9 billion, or $53.00 per share. The consideration represents approximately a 54% percent premium to Cepheid’s common stock over the closing price of $34.42 on September 2,... Read More »